Company intelligence / Profile preview

Genova Biopharmaceuticals

Pune, Mahārāshtra, India

Ownership: Private
Employees: ~567
Development stage: Other

Overview

Gennova has commercialized nine biotherapeutic products including five biosimilars, one generic, and pioneering first-in-world products. The company is a market leader in four of its commercialized products and has expanded its pipeline to include mRNA vaccines for multiple infectious diseases.

Therapeutic areas: OncologyCardiovascularInfectious Diseases
Modalities: BiosimilarRecombinant proteinmRNA-based drugsVaccineDNA vaccineLive biotherapeutic product therapy
Industry: Biotech

Partnerships

US FDAMcGill UniversityOhio State UniversityNekken Institute of Tropical MedicineNational Institutes of HealthJohns Hopkins UniversityTata Memorial HospitalIDRI (for visceral leishmaniasis vaccine)

Beyond the preview

Go deeper on Genova Biopharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genova Biopharmaceuticals.

Explore the full profile